Texas 2023 88th Regular

Texas House Bill HB25 Introduced / Bill

Filed 11/15/2022

Download
.pdf .doc .html
                    By: Talarico H.B. No. 25


 A BILL TO BE ENTITLED
 AN ACT
 relating to wholesale importation of prescription drugs for resale
 to Texas residents.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  SHORT TITLE. This Act shall be known as the
 "Wholesale Prescription Drug Importation Act."
 SECTION 2.  WHOLESALE PRESCRIPTION DRUG IMPORTATION
 PROGRAM. Subtitle C, Title 2, Health and Safety Code is amended by
 adding Chapter 66 to read as follows:
 CHAPTER 66.  WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM
 SUBCHAPTER A.  GENERAL PROVISIONS.
 Sec. 66.001.  DEFINITIONS. In this chapter:
 (1)  "Canadian supplier" means a manufacturer, wholesale
 distributor or pharmacy that is appropriately licensed or permitted
 under Canadian federal or provincial laws and rules to manufacture,
 distribute or dispense prescription drugs.
 (2)  "Commission" means Health and Human Services
 Commission.
 (3)  "Eligible prescription drug" means a drug eligible for
 importation that:
 (a)  meets the United States federal food and drug
 administration's standards related to safety, effectiveness,
 misbranding and adulteration;
 (b)  does not violate federal patent laws;
 (c)  is expected to generate cost savings; and
 (d)  is not a controlled substance;
 (4)  "Program" means the wholesale prescription drug
 importation program; and
 (5)  "State drug wholesaler" means a licensed wholesale drug
 distributor that contracts with the state to import eligible
 prescription drugs from a Canadian supplier.
 Sec. 66.002.  CONSTRUCTION OF CHAPTER; PURPOSE.  (a) The
 purpose of this chapter is to establish a program to make
 prescription drugs that are available at lower costs outside the
 United States available to consumers in Texas at those lower costs.
 Sec. 66.003.  ESTABLISHMENT OF WHOLESALE PRESCRIPTION DRUG
 IMPORTATION PROGRAM.  (a) The commission shall design a "wholesale
 prescription drug importation program" that complies with the
 applicable requirements of 21 U.S.C. Section 384, including the
 requirements regarding safety and cost savings. The commission
 shall explore all potential mechanisms, to the extent allowable
 under law, for the importation of eligible prescription drugs. The
 program design shall:
 (1)  contract with one or more state drug wholesalers
 to seek federal certification and approval to import safe, eligible
 prescription drugs from Canadian suppliers and provide significant
 prescription drug cost savings to Texas consumers;
 (2)  allow the importation of eligible prescription
 drugs sold by Canadian suppliers;
 (3)  ensure that only eligible prescription drugs
 meeting the United States food and drug administration's safety,
 effectiveness and other standards are imported by or on behalf of
 the state;
 (4)  import only those eligible prescription drugs
 expected to generate substantial savings for Texas consumers;
 (5)  ensure that, with respect to eligible prescription
 drugs to be imported pursuant to the program, the program and the
 state drug wholesaler comply with the tracking, tracing,
 verification and identification requirements of 21 U.S.C. Sections
 360eee and 360eee-1;
 (6)  prohibit the distribution, dispensing or sale of
 eligible prescription drugs imported pursuant to the Wholesale
 Prescription Drug Importation Act outside the exterior boundaries
 of the state;
 (7)  recommend a charge per prescription or another
 method of support to ensure that the program is funded adequately in
 a manner that does not jeopardize significant consumer savings; and
 (8)  include an audit function.
 Sec. 66.004.  MONITORING FOR ANTI-COMPETITIVE
 BEHAVIOR.  (a) The commission shall consult with the attorney
 general to identify the potential, and to monitor, for
 anti-competitive behavior in industries that would be affected by
 the program.
 Sec. 66.005.  FEDERAL COMPLIANCE.  (a) The commission shall
 submit a formal request to the secretary of the United States
 department of health and human services for certification of the
 state's program.
 Sec. 66.006.  IMPLEMENTATION.  (a) Upon certification of
 approval by the secretary of the United States department of health
 and human services, the commission shall begin implementing the
 program and begin operating the program within six months of that
 approval. As part of the implementation process, the commission
 shall:
 (1)  enter into contracts in accordance with the
 Procurement Code with one or more state drug wholesalers and Texas
 licensed drug distributors and contract with one or more approved
 Canadian suppliers;
 (2)  consult with interested stakeholders, including
 the committee, the legislature, health insurance plans, employers,
 pharmacies, health care providers and consumers;
 (3)  develop a registration process for health
 insurance plans, pharmacies and prescription drug administering
 health care providers who choose to participate in the program;
 (4)  make a list of imported eligible prescription
 drugs and their prices and make that list available to all
 participating entities and the general public;
 (5)  create an outreach and marketing plan to generate
 program awareness;
 (6)  create and staff a helpline to answer questions
 and address the needs of consumers, employers, health insurance
 plans, pharmacies, health care providers and other affected
 sectors;
 (7)  require annual specific audits of the program; and
 (8)  carry out other duties in accordance with the
 Wholesale Prescription Drug Importation Act that the commission
 determines to be necessary for successful implementation of the
 program.
 Sec. 66.007.  ANNUAL REPORTING.  (a) Annually, after
 implementation, the commission shall report to the governor and the
 legislature regarding the operation of the program during the
 previous year, including:
 (1)  which eligible prescription drugs and Canadian
 suppliers are included in the program;
 (2)  the number of participating pharmacies, health
 care providers and health insurance plans;
 (3)  the number of prescriptions dispensed through the
 program;
 (4)  the estimated savings to consumers, health plans,
 employers and the state during the previous year and to date;
 (5)  information regarding implementation of the audit
 plan and the correction plans for audit findings; and
 (6)  any other information requested by the governor or
 the legislature or state health authority deems relevant.
 Sec. 66.008.  COUNTRIES OTHER THAN CANADA ALLOWED BY FEDERAL
 LAW.  (a)  The provisions of the Wholesale Prescription Drug
 Importation Act may be extended to any other country allowed by
 federal law to import prescription drugs into the United States, at
 the discretion of the commission.
 SECTION 3.  As soon as practicable after the effective date
 of this Act, the executive commissioner of the Health and Human
 Services Commission and any other state agency designated by the
 executive commissioner shall adopt rules necessary to implement
 Chapter 66, Health and Safety Code, as added by this Act.
 SECTION 4.  This Act takes effect September 1, 2023.